Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.98 and traded as low as $3.11. Predictive Oncology shares last traded at $3.11, with a volume of 20,587 shares.
Predictive Oncology Price Performance
The stock has a market cap of $11.62 million, a PE ratio of -0.63 and a beta of 1.57. The company’s fifty day moving average is $3.31 and its 200-day moving average is $3.97.
In other news, Director Charles Lee Sr Nuzum, Sr. sold 10,000 shares of the business’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $3.04, for a total value of $30,400.00. Following the completion of the transaction, the director now owns 24,033 shares of the company’s stock, valued at approximately $73,060.32. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.26% of the company’s stock.
Hedge Funds Weigh In On Predictive Oncology
About Predictive Oncology
Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.
- Five stocks we like better than Predictive Oncology
- How to Invest in Canada for Beginners
- 3 large caps with red hot RSIs with upside
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Johnson Controls International: Nothing but upside for investors
- What Does the Consumer Price Index Measure?
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.